0001209191-23-036042.txt : 20230609 0001209191-23-036042.hdr.sgml : 20230609 20230609185219 ACCESSION NUMBER: 0001209191-23-036042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wood Todd Michael CENTRAL INDEX KEY: 0001739840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38118 FILM NUMBER: 231006737 MAIL ADDRESS: STREET 1: C/O OBALON THERAPEUTICS, INC. STREET 2: 5421 AVENIDA ENCINAS, SUITE F CITY: SAN DIEGO STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DermTech, Inc. CENTRAL INDEX KEY: 0001651944 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 842870849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12340 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-450-4222 MAIL ADDRESS: STREET 1: 12340 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Constellation Alpha Capital Corp. DATE OF NAME CHANGE: 20150827 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-07 0 0001651944 DermTech, Inc. DMTK 0001739840 Wood Todd Michael C/O DERMTECH, INC. 12340 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-06-07 4 S 0 189 2.53 D 289910 D Common Stock 2023-06-07 4 S 0 2254 2.53 D 287656 D Common Stock 2023-06-07 4 S 0 2549 2.53 D 285107 D The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 7, 2023. /s/ Mo Tashakor, attorney-in-fact 2023-06-09